We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Microsaic Systems Plc | LSE:MSYS | London | Ordinary Share | GB00BMWC8365 | ORD GBP0.00001 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.825 | 0.80 | 0.85 | 0.85 | 0.825 | 0.83 | 279,444 | 08:00:19 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Electronic Components, Nec | 492k | -2.6M | -0.0145 | -0.57 | 1.48M |
Date | Subject | Author | Discuss |
---|---|---|---|
17/12/2021 13:53 | Shocking really and taking PIs for mugs | mrscocker | |
17/12/2021 13:45 | GB and TP and mates are going to have best xmas ever. Don't give them any more of your money until confirmed revenue contracts (unless of course DVRG placing at 30p money is given in contracts to MSYS which he is a director and wife a large share holder at 0.1p!!!). People fed up and quite rightly showing it, a bit like Boris. Here is how many 0.1p shares there were and many more option shares. TP made mega money... plus 20% more of those below were available!!! DID they get taken up, no one knows! look where the warrants went to and none exercised yet!! interesting 1 year left to admit those shares. the issuance of Broker Warrants, whereby transferable warrants are to be issued to JIM Nominees Limited (as nominee on behalf of Turner Pope) for up to 997,000,000 New Ordinary Shares, equivalent to 20 per cent. of the Placing Shares issued to non-director placees, exercisable at the Placing Price for two years from Admission, as part of the consideration payable to Turner Pope for its services as placing agent to the Transaction; 19/1/21 RNS Microsaic, the high technology company which develops point-of-need mass spectrometers, designed to improve the efficiency of chemical and biological workflows , announces that it has through Turner Pope Investments (TPI) Ltd ("Turner Pope") conditionally raised GBP5 million, before expenses, by way of an oversubscribed placing ("Placing") of 5,000,000,000 new Ordinary Shares ("Placing Shares") at a price of 0.1 pence per New Ordinary Share ("Placing Price"). A Conditional Broker Option granted to Turner Pope of up to 500,000,000 New Ordinary Shares ("Broker Option Shares") at a price of 0.1 pence per New Ordinary Share is open until 5.00 p.m. on 22 January 2021. It is intended that Gerard Brandon will join the Board as Non-executive Chairman and Dr Nigel Burton will join the Board as a Non-executive Director, in each case immediately upon completion of the proposed Placing, at which time the current Non-executive Chairman, Peter Grant and Non-executive Director, Eric Yeatman, will also step down from the Board. Eric Yeatman will be retained as a consultant to the Company. The Transaction is, amongst other things, conditional upon each of the Resolutions being passed at the forthcoming General Meeting and includes: -- a Placing with certain institutional and other investors, to raise GBP5.0 million before expenses through the issue of 5,000,000,000 New Ordinary Shares at the Placing Price of 0.1 pence per New Ordinary Share. -- the Placing Price is at a discount of approximately 50 per cent. to the closing middle market price of 0.2 pence per Existing Ordinary Share on 15 January 2021, being the latest practicable date prior to the publication of this announcement; -- a Broker Option whereby the Broker, Turner Pope may conditionally allocate up to 500,000,000 New Ordinary Shares (in addition to the Placing Shares) (the "Broker Option Shares") at the Placing Price in order to give the flexibility to meet any additional demand for New Ordinary Shares arising during the period from the announcement of the Transaction up to 5.00 p.m. on 22 January 2021; -- the issuance of the Fees Shares, whereby (i) 35,000,000 New Ordinary Shares are to be issued at the Placing Price in respect of the first year of fees due to Turner Pope for the provision of its broking services to the Company and (ii) 85,000,000 New Ordinary Shares are to be issued at the Placing Price in settlement of the first year's fees of the Proposed Directors; -- the issuance of Broker Warrants, whereby transferable warrants are to be issued to JIM Nominees Limited (as nominee on behalf of Turner Pope) for up to 997,000,000 New Ordinary Shares, equivalent to 20 per cent. of the Placing Shares issued to non-director placees, exercisable at the Placing Price for two years from Admission, as part of the consideration payable to Turner Pope for its services as placing agent to the Transaction; -- proposed Board changes and proposed directors being appointed on the terms summarised in Section 9 below, and proposed Director Options and Warrants over 750,000,000 New Ordinary Shares on the terms and subject to the performance condition set out in Section 10 below; and -- a Share Reorganisation, further details of which are set out in Section 5 below, to enable shares to be issued at the Placing Price, which is below the current nominal value of the Ordinary Shares. The proceeds receivable by the Company from the Transaction on Admission amount to GBP5.0 million (before expenses) and approximately GBP4.6 million (net of expenses) (assuming that no Broker Option Shares are issued). If the Broker Option Shares are issued in full, the proceeds receivable by the Company from the Transaction amount to GBP5.5 million (before expenses) and approximately GBP5.0 million (net of expenses). | onehanded | |
13/12/2021 15:29 | Poly- and perfluoroalkyl substances (PFAS): sources, pathways and environmental dataChief Scientist's Group report.https://asset | ragnarr | |
13/12/2021 15:10 | yes the more you look at it, what a bad deal. This company could have been bought for 1 million pounds at the time of nearly going into liquidation when the above deal with the above RNS was done. Wish I had sold my other half today on that rise. Hold and wait... at least more interest seen on BB here today lol. | onehanded | |
13/12/2021 14:53 | Now that a truely terrible deal that has totally shafted an PIs involved with MSYS ever since. Problem is that the overhang of cheap stock is almost endless when you issue 5 billion discounted shares. Gerry has always maintained they wen to sticky holders, maybe some did but there's an awful lot that have been sold for handsome profits throughout 2021. Until MSYS can deliver a deal than justifies a significantly higher MCAP it will never get the rerating many of us want. Significant shareholders (3% and above) At 30 September 2021: Significant Shareholder % Held Unicorn Asset Mgt 12.34% Hargreaves Lansdown Asset Mgt 12.06% Jarvis Investment Mgt 9.28% Premier Miton Investors 7.93% Helium Rising Stars Fund 7.84% Interactive Investor 6.51% Intuitive Investments Group 4.11% Microsaic Systems plc Director & Related Holdings 3.66% Halifax Share Dealing 3.44% Barclays Wealth 3.25% | mrscocker | |
13/12/2021 14:33 | Here is how many 0.1p shares there were and many more option shares. TP made mega money... plus 20% more of those below were available!!! DID they get taken up, no one knows! look where the warrants went to and none exercised yet!! interesting 1 year left to admit those shares. the issuance of Broker Warrants, whereby transferable warrants are to be issued to JIM Nominees Limited (as nominee on behalf of Turner Pope) for up to 997,000,000 New Ordinary Shares, equivalent to 20 per cent. of the Placing Shares issued to non-director placees, exercisable at the Placing Price for two years from Admission, as part of the consideration payable to Turner Pope for its services as placing agent to the Transaction; 19/1/21 RNS Microsaic, the high technology company which develops point-of-need mass spectrometers, designed to improve the efficiency of chemical and biological workflows , announces that it has through Turner Pope Investments (TPI) Ltd ("Turner Pope") conditionally raised GBP5 million, before expenses, by way of an oversubscribed placing ("Placing") of 5,000,000,000 new Ordinary Shares ("Placing Shares") at a price of 0.1 pence per New Ordinary Share ("Placing Price"). A Conditional Broker Option granted to Turner Pope of up to 500,000,000 New Ordinary Shares ("Broker Option Shares") at a price of 0.1 pence per New Ordinary Share is open until 5.00 p.m. on 22 January 2021. It is intended that Gerard Brandon will join the Board as Non-executive Chairman and Dr Nigel Burton will join the Board as a Non-executive Director, in each case immediately upon completion of the proposed Placing, at which time the current Non-executive Chairman, Peter Grant and Non-executive Director, Eric Yeatman, will also step down from the Board. Eric Yeatman will be retained as a consultant to the Company. The Transaction is, amongst other things, conditional upon each of the Resolutions being passed at the forthcoming General Meeting and includes: -- a Placing with certain institutional and other investors, to raise GBP5.0 million before expenses through the issue of 5,000,000,000 New Ordinary Shares at the Placing Price of 0.1 pence per New Ordinary Share. -- the Placing Price is at a discount of approximately 50 per cent. to the closing middle market price of 0.2 pence per Existing Ordinary Share on 15 January 2021, being the latest practicable date prior to the publication of this announcement; -- a Broker Option whereby the Broker, Turner Pope may conditionally allocate up to 500,000,000 New Ordinary Shares (in addition to the Placing Shares) (the "Broker Option Shares") at the Placing Price in order to give the flexibility to meet any additional demand for New Ordinary Shares arising during the period from the announcement of the Transaction up to 5.00 p.m. on 22 January 2021; -- the issuance of the Fees Shares, whereby (i) 35,000,000 New Ordinary Shares are to be issued at the Placing Price in respect of the first year of fees due to Turner Pope for the provision of its broking services to the Company and (ii) 85,000,000 New Ordinary Shares are to be issued at the Placing Price in settlement of the first year's fees of the Proposed Directors; -- the issuance of Broker Warrants, whereby transferable warrants are to be issued to JIM Nominees Limited (as nominee on behalf of Turner Pope) for up to 997,000,000 New Ordinary Shares, equivalent to 20 per cent. of the Placing Shares issued to non-director placees, exercisable at the Placing Price for two years from Admission, as part of the consideration payable to Turner Pope for its services as placing agent to the Transaction; -- proposed Board changes and proposed directors being appointed on the terms summarised in Section 9 below, and proposed Director Options and Warrants over 750,000,000 New Ordinary Shares on the terms and subject to the performance condition set out in Section 10 below; and -- a Share Reorganisation, further details of which are set out in Section 5 below, to enable shares to be issued at the Placing Price, which is below the current nominal value of the Ordinary Shares. The proceeds receivable by the Company from the Transaction on Admission amount to GBP5.0 million (before expenses) and approximately GBP4.6 million (net of expenses) (assuming that no Broker Option Shares are issued). If the Broker Option Shares are issued in full, the proceeds receivable by the Company from the Transaction amount to GBP5.5 million (before expenses) and approximately GBP5.0 million (net of expenses). | onehanded | |
13/12/2021 14:30 | All pure speculation - Henry Ford said.Speculation is only a word covering the making of money out of the manipulation of prices, instead of supplying goods and services.Skol | ragnarr | |
13/12/2021 14:14 | Will be another few years before DVRG will buy MSYS. MSYS from the original takeover gave away billions of shares and warrants at 0.1p, a lot of these are still held (check RNS who has sold a few), the big problem is the warrants as none have been sold from RNS news. DVRG would need to get rid of them before really making any move. I think that the possibility of a acquisition from DVRG caused a lot of DVRG share holders to buy here (as me) but now seems less and less likely in the near future and that's why I sold half today on that rise. We will see..... | onehanded | |
13/12/2021 12:37 | I held DVRG for a few months, lost patience & sold for a small profit, a few months ago. With view to the common Directors etc is there a chance that DVRG will acquire MSYS at some point - & if there is any chance of success , presumably before MSYS announce any too many contract wins ? | base7 | |
13/12/2021 09:49 | What like China Medical sales perhaps, news on that should be released very soon. | mrscocker | |
13/12/2021 09:43 | Afraid MSYS is too dependant on DVRG and the relationship with mutual directors/shareholde Like DVRG the company needs genuine sales to genuine 3rd parties. | angus17 | |
13/12/2021 09:16 | And back down again. One day this will move up and stay up, but when is anyone's guess. | mrscocker | |
13/12/2021 09:01 | Bye then onehanded. Quite how you made a "good profit" I don't know but each to their own. | mrscocker | |
13/12/2021 08:58 | Angus are you just repeating what blueteam has been saying for months on the dvrg page? He has never been able to explain or support his claim so at this time I would challenge that claim and say is it's total BS. Only problem here is the selling down by cheap placees. | mrscocker | |
13/12/2021 08:57 | just sold some more a while back and now sold half my holding. Good profit and spend on xmas lol. Selling on rise and at this time of the year, it get's into the bank just in time for a good xmas and new year lol. Won't be reinvesting any more this year into anything. | onehanded | |
13/12/2021 08:30 | Delusional! | david gruen | |
13/12/2021 08:29 | Smoke and mirrors I'm afraid. Placing at .15 coming so bank any of today's rise. | angus17 | |
13/12/2021 08:29 | just top sliced my holding here to bank profit. Good rise on what appears a small contract with Deepverge. Have Micro enough money left from the 0.1p massive placing and warrants a while back. They are expanding and as RNS says developing new phase which costs a lot of money, but small revenue. Will keep the rest and wait. If rises any more may get ride of a few more. Saying that progress on Msys is growing. | onehanded | |
13/12/2021 07:39 | 13 December 2021 Microsaic Systems plc ("Microsaic" or the "Company") Microsaic to supply mass spectrometry equipment for DeepVerge Modern Water Mobile Services for pathogen detection, adding the detection of forever chemicals in soil and water Microsaic (AIM: MSYS), is pleased to announce that it has received a further order from DeepVerge plc ("DeepVerge") for additional miniaturised mass spectrometry ("MS") equipment and services (the "Order"). The value of the Order is approximately GBP262k and part of the order (the "Further Order") is being fulfilled pursuant to the Company's existing Framework Services Agreement (the "Agreement") with DeepVerge, as announced on 24 March 2021 and referenced in the trading update on 6 July 2021 referring to a subsequent order under the Agreement. Additionally, the Order includes a number of units of Microsaic's newly developed solid phase extraction - liquid chromatography ("SPE-LC") Systems, which do not form part of the Agreement, and related consumables which will be used for quality and contamination detection in a range of markets including water and soil analysis (the "New Order"). As announced on 6 July 2021, Microsaic had previously loaned this equipment to DeepVerge, to enable an early evaluation of certain technical aspects of its potential use in detecting a range of chemical contaminants, referred to as Chemicals of Emerging Concern ("CEC"), including forever chemicals. It is expected that equipment with a value of up to approximately GBP94k will be shipped by Microsaic in the current financial year, with the remainder of the Order to be fulfilled as soon as practicably possible in 2022. The SPE-LC System is expected to be used to detect CECs in water, and will be supplied to DeepVerge to form part of DeepVerge's third generation solution of multiplex pathogen detection and the launch of its Modern Water Mobile Services, which will facilitate auto-sampling at wastewater sites to reduce the time and cost of detection. Further information on the scope of the system can be found in the announcement by DeepVerge released today. Glenn Tracey, CEO of Microsaic, commented: "This order once again exemplifies the close working partnership between DeepVerge and Microsaic, and our aligned approach to the application of miniaturised but powerful detection technologies, used at the point of need." | david gruen | |
10/12/2021 13:10 | Worth watching as directly involves MSYS. potentially huge.https://www.you | ragnarr | |
09/12/2021 15:58 | I managed to pop another 8k into the DVRG proxy (MSYS) before the realisation kicked in. An absolute no-brainer at these levels. One for the SIPP if ever I saw one. | david gruen |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions